With the aim of contributing to people’s health, Toyo Shinyaku Sha, ビット カジノ 違法harmaceutical’s predecessor company, was established in 1923 and began manufacturing and selling injection-type medicines. During the 1960s, we built a structure for the research and development of new drugs. Since then, we have continued to contribute to people’s health through the research and development, manufacture, and sales of new medicines.
Going forward, we will strive to create high value new drugs that meet medical needs and to enhance corporate value, while continuing to grow as a company that makes a wide ranging contribution to people’s health.
- The purple border isCompany history
- The orange border isProduct history
1923年～
1923年
Toyo Shinyaku Sha, the predecessor of ビット カジノ 違法harmaceutical Co., Ltd., was founded.
1931年
Kyorin Chemical Laboratory was established.
1940年
Kyorin Chemical Laboratory was renamed ビット カジノ 違法harmaceutical Co., Ltd., and Kyorin Yakuhin Co., Ltd. was organized as an independent marketing division.
1947年
The Okaya Plant was started.
1950年～
1957年
The medical journal bulletin “Doctor Salon” was started.
1961年
Behyd, a diuretic and antihypertensive agent, ビット カジノ 違法aunched.
1962年
Kyorin Chemical Laboratory (later Technical Center of Development) was established.
1965年
The Head Office was completed in Kanda Surugadai.
KYORIN AP-2, an analgesic, ビット カジノ 違法aunched.
Deamelin-S, an oral hypoglycemic agent, ビット カジノ 違法aunched.
1967年
The Nogi Plant was opened.
1971年
Cholexamin, a lipid metabolism and peripheral circulation improving agent, ビット カジノ 違法aunched.
1974年
Hespander, a plasma substitute and extracorporeal circulation flow improver, ビット カジノ 違法aunched.
1977年
Central Research Laboratories were opened.
1980年～
1980年
Norfloxacin (NFLX), an antibacterial agent, ビット カジノ 違法icensed to Merck & Co. (U.S.A.).
1981年
Mucodyne, a mucoregulant, ビット カジノ 違法aunched.
1984年
Baccidal (NFLX), a broadspectrum oral antibacterial agent, ビット カジノ 違法aunched.
1989年
Ketas, for bronchial asthma and cerebrovascular disorders, ビット カジノ 違法aunched.
Baccidal Eyedrops, a broadspectrum ophthalmic antibacterial agent, ビット カジノ 違法aunched.
1992年
ビット カジノ 違法harmaceutical Co., Ltd. and Kyorin Yakuhin Co., Ltd. were merged, and the new ビット カジノ 違法harmaceutical Co., Ltd. was founded.
1993年
Megalocin (FLRX), a long-acting new quinolone agent, ビット カジノ 違法aunched.
1995年
The Noshiro Plant was opened.
1996年
A joint venture, Nisshin ビット カジノ 違法harmaceutical Co., Ltd., was established with Kyorin’s capital participation.
The Research Center (now the WATARASE Research Center) was founded.
Pentasa, a treatment for ulcerative colitis and Crohn’s disease, ビット カジノ 違法aunched.
Gatifloxacin (GFLX) ビット カジノ 違法icensed to Bristol-Myers Squibb (U.S.A.).
1998年
Milton, an effervescent disinfectant business, was acquired from P&G.
1999年
Listed on the Tokyo Stock Exchange, Second Section.
2000年
Listed on the Tokyo Stock Exchange, First Section.
Gatifloxacin eyedrops ビット カジノ 違法icensed to Allergan (U.S.A.).
2000年～
2001年
A subsidiary company, Kyorin USA, Inc. (U.S.A.), was established.
Kipres, the leukotriene receptor antagonist and bronchial asthma treatment medicine, ビット カジノ 違法aunched.
2002年
A subsidiary company, Kyorin Europe GmbH (Germany), was established.
Gatiflo (GFLX), a broad-spectrum, oral antibacterial agent, ビット カジノ 違法aunched.
2004年
ActivX Biosciences, Inc. (U.S.A.) became a wholly owned subsidiary.
2005年
The stock of Toyo Pharma Co., Ltd. (present KYORIN Rimedio Co., Ltd.) was acquired, making it into a subsidiary company.
2006年
The Nogi Plant was closed.
The Kyorin Group shifts to a holding company structure through a share exchange with KYORIN Co., Ltd.
2007年
Uritos Tablets 0.1 mg, an overactive bladder drug, ビット カジノ 違法aunched.
2008年
ビット カジノ 違法harmaceutical merged with Nissin ビット カジノ 違法harmaceutical.
2010年
KYORIN Co., Ltd. changed its name to KYORIN Holdings, Inc.
2010年～
2012年
Acquisition (conversion into subsidiary) of the Shiga Plant of MSD K.K. and established ビット カジノ 違法harmaceutical Facilities Co., Ltd.
RUBYSTA, a multi-purpose disinfectant cleaner, ビット カジノ 違法aunched.
2013年
Head office moved to Ochanomizu sola city in Kanda Surugadai.
Flutiform, a combination drug for asthma treatment, ビット カジノ 違法aunched.
2015年
Establishment of the WATARASE Research Center of ビット カジノ 違法harmaceutical Co., Ltd. through consolidation of the Drug Discovery Center (the former Central Research Laboratories) and the R&D Center (the former Research Center).
Eklira Genuair, a treatment for COPD, ビット カジノ 違法aunched.
FPR2 agonist program ビット カジノ 違法icensed to Bristol-Myers Squibb Company (U.S.A.)
2016年
The Okaya Plant was closed
Montelukast tablets 10mg, 5mg「KM」, the leukotriene receptor antagonist and bronchial asthma treatment medicine, ビット カジノ 違法aunched.
DESALEX Tablets 5mg a treatment of allergic diseases drug ビット カジノ 違法aunched売
2017年
KYORIN Rimedio Co., Ltd.’s Takaoka Pharmaceutical Technology Innovation Center was established.
2018年
New manufacturing subsidiary, ビット カジノ 違法harmaceutical Group Facilities Co., Ltd. (head office: Tokyo), commences operations.
Beova Tablets 50mg a treatment of OAB drug ビット カジノ 違法aunched.
2019年
GeneSoC®, a microchannel-based genetic measurement device, ビット カジノ 違法aunched.
2020年
ビット カジノ 違法harmaceutical Group Facilities Co., Ltd. and KYORIN Medical Supply Co., Ltd. merge.
Lasvic Tablets 75mg an oral quinolone antibacterial agent ビット カジノ 違法aunched.
2020年～
2021年
Lasvic Intravenous Drip Infusion Kit 150mg an injectable new quinolone antibacterial agent ビット カジノ 違法aunched.
Zymso Intravesical Solution 50%, an interstitial cystitis treatmet ビット カジノ 違法aunched.
GeneSoC® mini ビット カジノ 違法aunched.
2022年
Lyfnua® Tablets 45mg Selective P2X3 receptor antagonist/Refractory chronic cough ビット カジノ 違法aunched.
ActivX Biosciences, Inc. was dissolved.
2023年
KYORIN Holdings, Inc. changed its trade name to ビット カジノ 違法harmaceutical Co., Ltd. through absorption type merger of ビット カジノ 違法harmaceutical Co., Ltd.